While this pattern is compatible with previous observations in non-CKD patients showing a correlation between higher AZGP1 levels and reduced incidence of coronary heart disease and atherosclerosis scores (14, 15), it is in conflict with findings in dialysis patients where higher AZGP1 levels positively correlated with cardiovascular events and mortality (16). Here, AZGP1 is linked to coronary artery disorder.